In the present study, we found that Piezo1 expression was high in the CD133+CD44+ CCSC fraction, and the Piezo1high/CD133+CD44+ colon cancer patients were in the advanced clinical stage. The gene discussed is PROM1; the disease is malignant colon neoplasm.